Global Point-of-Care-Ultrasound Device Market – Industry Trends and Forecast to 2030

Point-of-Care-Ultrasound Device Market Analysis and Size

Point-of-Care-Ultrasound Device are portable ultrasonography for diagnostic and therapeutic applications at the patient’s bedside. Some of the major driving factors in this market are the increasing use of point-of-care ultrasonography in emergency rooms, global birth rates rising, point-of-care ultrasound system improvements and technological developments in developed economies, and increasing disease burden and a base of geriatrics that is expanding quickly. The increased frequency of chronic diseases and the growing demand for point-of-care in emergency rooms will ultimately promote market expansion.                       

Data Bridge Market Research analyses that the global point-of-care-ultrasound device market which was USD 2,324.12 million in 2022, is expected to reach USD 3,941.12 million by 2030, and is expected to undergo a CAGR of 6.0% during the forecast period of 2023 to 2030. “Diagnostic” dominates the type segment of the global point-of-care-ultrasound device market due to increase in the incidences of target diseases and infectious diseases. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Point-of-Care-Ultrasound Device Market Scope and Segmentation

Market Definition

PoCUS devices are another name for point-of-care ultrasound equipment. It describes the use of portable ultrasonography for diagnostic and therapeutic applications at the patient’s bedside. POCUS enables medical professionals to treat patients more quickly, accurately, and non-invasively, doing away with the need for the Radiology department. An increasing number of patients are receiving their initial care and diagnostic tests in emergency rooms due to the dynamic nature of health care delivery in the United States (EDs).

Global Point-of-Care-Ultrasound Device Market Dynamics

Drivers

• Increased Demand for Bedside Imaging

The growing demand for point-of-care ultrasound devices is driven by the need for real-time imaging and diagnostics at the patient's bedside. These devices provide rapid access to critical information, enabling healthcare professionals to make timely decisions, especially in emergency and critical care settings.

• Technological Advancements in Point-of-Care-Ultrasound Device

Ongoing technological advancements have resulted in more compact, portable, and user-friendly ultrasound devices. These innovations include miniaturized transducers, improved image quality, and enhanced software capabilities. Such advancements have expanded the scope of point-of-care ultrasound beyond traditional applications, creating new growth opportunities.

• Rise in Chronic Diseases

The global rise in chronic diseases, such as cardiovascular conditions, diabetes, and obesity, has increased the demand for regular monitoring and early disease detection. Point-of-care ultrasound devices offer a non-invasive and cost-effective means of assessing and managing these conditions, leading to their wider adoption.

Opportunities

• Telemedicine and Remote Monitoring

The trend toward remote patient monitoring and home-based healthcare creates opportunities for point-of-care ultrasound devices. Patients with chronic conditions can benefit from regular monitoring using portable devices, reducing the need for frequent hospital visits.

• Emerging and Markets Expansion

The expansion of telemedicine and remote care services, accelerated by the COVID-19 pandemic, has driven the adoption of point-of-care ultrasound devices. These devices enable remote healthcare professionals to conduct virtual examinations, diagnose conditions, and guide patients through treatment plans, enhancing access to care.

Restraints/Challenges

• High Initial Costs of Point-of-Care Ultrasound Devices

Point-of-care ultrasound devices, while portable and versatile, can be expensive to procure. The initial capital investment required for these devices may pose a barrier, particularly for smaller healthcare facilities and resource-constrained regions.

• Limited Imaging Capabilities

While point-of-care ultrasound devices are valuable for quick assessments and screenings, they may have limitations in terms of advanced imaging capabilities compared to larger, more specialized ultrasound machines. This can restrict their use in complex diagnostic scenarios.

This global point-of-care-ultrasound device market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global point-of-care-ultrasound device market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In Mar 2022, Exo, a leading provider of medical devices and information, recently announced Exo WorksTM, a smart and user-friendly point-of-care ultrasound workflow solution that enables doctors to quickly and effectively document, evaluate, bill, and manage quality assurance all from one platform

Global Point-of-Care-Ultrasound Device Market Scope

The global point-of-care-ultrasound device market is segmented on the basis of type, portability, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Diagnostic
• Therapeutic

Portability

• Trolley/ Cart-Based
• Compact/ Handheld

Application

• Emergency Medicine
• Cardiology
• Obstetrics and Gynecology
• Oncology Surgery
• Urology
• Vascular surgery
• Musculoskeletal
• Others

End User

• Hospitals
• Diagnostic Centers
• Research Laboratories
• Clinics
• Ambulatory Surgical Centers
• Others

Global Point-of-Care-Ultrasound Device Market Regional Analysis/Insights

The global point-of-care-ultrasound device market is analysed and market size insights and trends are provided by country, type, portability, application and end user as referenced above.

The countries covered in the global point-of-care-ultrasound device market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the global point-of-care-ultrasound device market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period of 2023 to 2030, due of the increase in the expenditure for research and development proficiencies, increasing government’s initiatives and improved health care infrastructure in various countries.

Asia-Pacific on the other hand is projected to exhibit the highest growth rate in the global point-of-care-ultrasound device market during the forecast period of 2023 to 2030 owing to the increasing government expenditure on healthcare sector and rising technological advancements and initiatives by the government.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global point-of-care-ultrasound device market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global point-of-care-ultrasound device market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global point-of-care-ultrasound device market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Point-of-Care-Ultrasound Device Market Share Analysis

The global point-of-care-ultrasound device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global point-of-care-ultrasound device market.

Some of the major players operating in the global point-of-care-ultrasound device market are:

• GSK plc. (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Novartis AG (Switzerland)
• Astrazeneca (U.S.)
• Pfizer Inc. (U.S.)
• Bristol-Myers Squibb Company (U.S.)
• Sanofi (U.S.)
• Amgen Inc. (U.S.)
• Daiichi Sankyo Company Limited (Japan)
• AB Sciences (France)
• Eisai Co., Ltd (Japan)
• Genentech Inc. (U.S)
• Merck & Co., Inc. (U.S.)

SKU-62840